Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on: April 02,2024

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on:April 02,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on: April 30,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on:April 30,2024

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

Updated on: April 09,2024

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

Updated on:April 09,2024

Combination treatment improves survival in advanced prostate cancer with genetic mutations

by Melissa Rohman,Northwestern UniversityProstate cancer cells. Credit: NIH Image GalleryA combination therapy improved progression-free survival in patients with metastatic castration-resistant

Updated on: September 30,2024

Combination treatment improves survival in advanced prostate cancer with genetic mutations

by Melissa Rohman,Northwestern UniversityProstate cancer cells. Credit: NIH Image GalleryA combination therapy improved progression-free survival in patients with metastatic castration-resistant

Updated on:September 30,2024

Study reveals root of triple negative breast cancer immunosuppression and chemoresistance

by Hokkaido UniversityIn IL-34-expressing tumors, blood vessels were observed only in the outer layer, whereas in IL-34-deficient tumors, blood vessels were observed in the whole area (modified f

Updated on: February 20,2024

Study reveals root of triple negative breast cancer immunosuppression and chemoresistance

by Hokkaido UniversityIn IL-34-expressing tumors, blood vessels were observed only in the outer layer, whereas in IL-34-deficient tumors, blood vessels were observed in the whole area (modified f

Updated on:February 20,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024

Radiation doses from CT scans should be more consistent, say experts

by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t

Updated on: April 07,2024

Radiation doses from CT scans should be more consistent, say experts

by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t

Updated on:April 07,2024

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

Updated on: March 01,2024

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

Updated on:March 01,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on: July 08,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on:July 08,2024

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Updated on: June 01,2024

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Updated on:June 01,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on: January 12,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on:January 12,2024